Company · CIK 1998781

# IB Acquisition Corp.

| CIK | [1998781](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001998781) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 8731 — Services-Commercial Physical & Biological Research |
| Incorporated in | NV |
| Business address | FL |
| Listed | IBAC (Nasdaq), IBACR (Nasdaq) |
| First annual or quarterly report | 2024-05-15 |

## Offerings

 1 registration

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-275650 | IPO Final prospectus | 2023-11-17 | 2024-03-27 | 6 |

## Filings

 6

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2024-03-27 | [424B4](https://www.sec.gov/Archives/edgar/data/1998781/000149315224011561/0001493152-24-011561-index.htm) Final prospectus | 333-275650 | 0001493152-24-011561 |
| 2024-03-25 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1998781/999999999524000723/9999999995-24-000723-index.htm) Declared effective | 333-275650 | 9999999995-24-000723 |
| 2024-03-08 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1998781/000149315224009447/0001493152-24-009447-index.htm) Amendment | 333-275650 | 0001493152-24-009447 |
| 2024-01-31 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1998781/000149315224004380/0001493152-24-004380-index.htm) Amendment | 333-275650 | 0001493152-24-004380 |
| 2023-12-19 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1998781/000149315223045466/0001493152-23-045466-index.htm) Amendment | 333-275650 | 0001493152-23-045466 |
| 2023-11-17 | [S-1](https://www.sec.gov/Archives/edgar/data/1998781/000149315223041928/0001493152-23-041928-index.htm) Registration filed | 333-275650 | 0001493152-23-041928 |

[All filings of this company](https://equitycapital.markets/filings?cik=1998781) · [CSV](https://equitycapital.markets/filings.csv?cik=1998781)

---
Source page: https://equitycapital.markets/company/1998781 · Data: U.S. SEC EDGAR · CC BY 4.0